Similarly, in breast cancer, treatment of cells with DHT results in up to a 13-fold increase in the expression of miR-328-3p due to AR binding to the promoter of miR-328-3p[35]
As with virtually all research peptides, use during these periods is not recommended
The researchers concluded that AOD9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, zero serious adverse events were attributed to the peptide, and no participants withdrew due to treatment-related effects
Chirgadze D Y, Hepple J P, Zhou H, Byrd R A, Blundell T L and Gherardi E (1999) Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding
Research companies will continue to develop and supply these compounds to support growing metabolic research